Medicine, Hematology Oncology Division

Grants

Grants per year 1995 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2028

• 468 Active
• 1104 Finished

Grants per year

Search results

• Finished

  Adult Live Donor Liver Transplant: A Comparative Analysis

  Abecassis, M. M., Baker, T. B., Borensztajn, J., Kulik, L. M., Miller, F. H., Mulcahy, M. F. & Musunuri, S. R.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/17/02 → 8/31/09

  Project: Research project

  • Liver Transplantation 100%
  • Living Donors 92%
  • Tissue Donors 52%
  • Liver 21%
  • Hepatocellular Carcinoma 12%

• Study of TTP: Incidence Rates and Risk Factors

  Kwaan, H. C. & Kyriacou, D.

  National Heart, Lung, and Blood Institute

  9/9/02 → 8/31/07

  Project: Research project

  • Thrombotic Thrombocytopenic Purpura 100%
  • Incidence 22%
  • Clopidogrel 14%
  • Platelet Aggregation Inhibitors 14%
  • Rare Diseases 12%

• Action of Interferon in Chronic Myelogenous Leukemia

  Platanias, L. C.

  National Cancer Institute

  9/1/02 → 8/31/07

  Project: Research project

  • Interferon-alpha 100%
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive 87%
  • Interferons 51%
  • Phosphotransferases 17%
  • Monomeric GTP-Binding Proteins 13%

• Prot# COM1.3: Evaluation of Immunol Oral Rinse for the Management of Oral Mucositis in Cancer Patients Undergoing Radiation and/or Chemotherapy Conditioning for Autologous Bone Marrow Transplantation

  Mehta, J.

  Endo Pharmaceuticals Inc, BML Pharmaceuticals Inc.

  8/27/02 → 3/7/05

  Project: Research project

• Prot# EFC3558: Mltctr, Rndmzd, Dbl-Bld, Prl'l Grp Trial to Demonstrate Efficacy of Fondaparinux Sodium in Assoct'n w/ Intermittent Pneumatic Compression vs Intermittent Pneumatic Compression used Alone for Prevention of Venous Thromboembolic Events in Hig

  Green, D.

  Sanofi-Synthelabo Inc.

  8/21/02 → 1/1/11

  Project: Research project

• End of Life Nursing Education through Graduate Programs

  Paice, J.

  City of Hope National Medical Center and Beckman Research Institute, National Cancer Institute

  7/1/02 → 6/30/07

  Project: Research project

• West Hemophilia Treatment Center Network, Region V--MCHB Cooperative Grant

  Zakarija, A.

  Great Lakes Hemophilia Foundation, Maternal and Child Health Bureau

  6/1/02 → 5/31/12

  Project: Research project

• Prot# IDEC 114-20: A Phase I/II Trial of Anti-CD80 Monoclonal Antibody (IDEC-114) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

  Gordon, L. I.

  IDEC Pharmaceuticals Corporation

  4/23/02 → 1/1/11

  Project: Research project

• Prot# CEPO906A2212: An Open-Label, Phase IIa Trial Evaluating the Safety and Efficacy of EPO906 (Epothilone B) as Therapy in Patients with Metastatic Carcinoid Tumors

  Benson III, A. B.

  Novartis Pharmaceuticals Corporation

  4/1/02 → 3/3/10

  Project: Research project

• Prot# CpG-C010: A Phase II, Open Label, Multi-Center, Single Arm, Two-Stage Study for the Evaluation of CpG 7909 in Patients with Stage IV Renal Cell Carcinoma

  Kuzel, T. M.

  Coley Pharmaceutical Group, Inc.

  3/19/02 → 3/19/06

  Project: Research project

• HoxA10 Function During Myeloid Differentiation

  Eklund, E. A.

  National Cancer Institute

  2/6/02 → 1/31/08

  Project: Research project

  • neutrophil cytosol factor 67K 100%
  • Myelopoiesis 93%
  • Phosphorylation 74%
  • Myeloid Cells 66%
  • Tyrosine 59%

• Quality of Life Among Inner-City White and African-American Prostate Cancer Patients

  Chmiel, J. S., Golub, R. M., Kuzel, T. M. & Nadler, R. B.

  American Cancer Society

  1/1/02 → 12/31/06

  Project: Research project

• Prot# 524E-CVD-0042-029: Thromboprophylaxis with Low Molecular Weight Heparin (Fragmin) vs Warfarin in Patients Undergoing Primary Total Knee Replacement

  Green, D.

  Pharmacia & Upjohn, Inc.

  12/17/01 → 1/1/11

  Project: Research project

• Prot# C-100-12: A Multi-Center, Randomized Phase III Study of Adjuvant Oncophage® versus Observation in Patients with High Risk of Recurrence After Surgical Treatment for Renal Cell Carcinoma (NDDO Oncology Prot# ND 030012)

  Kuzel, T. M. & Kozlowski, J. M.

  Agenus Inc.

  10/7/01 → 1/1/11

  Project: Research project

• Recombinant Interleuckin-12 for Cutaneous T-Cell Lymphoma

  Kuzel, T. M.

  University of Pennsylvania, National Cancer Institute

  8/10/01 → 7/31/06

  Project: Research project

• The Robert H. Lurie Comprehensive Cancer Center: Protocol Specific

  Kuzel, T. M., Kuzel, T. M. & Kuzel, T. M.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • protocols 49%
  • biostatistics 15%
  • university research 12%
  • outreach 12%

• The Robert H. Lurie Comprehensive Cancer Center: Faculty Development Award for Dr. Eklund

  Eklund, E. A.

  National Cancer Institute

  8/1/01 → 7/31/02

  Project: Research project

  • neoplasms 100%
  • biostatistics 15%
  • university research 12%
  • outreach 12%
  • prostatic neoplasms 12%

• The Robert H. Lurie Comprehensive Cancer Center: Mouse Mutagenesis Development Core

  Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/06

  Project: Research project

  • neoplasms 100%
  • mutagenesis 66%
  • mice 40%
  • biostatistics 15%
  • university research 12%

• The Robert H. Lurie Comprehensive Cancer Center: Program Leaders

  Longnecker, R. M., Bulun, S. E., Catalona, W. J., Cella, D., Eklund, E. A., Lee, C., Longnecker, R. M., O'Halloran, T. V., Catalona, W. J., Eklund, E. A., Khan, S. A., Lee, C., Longnecker, R. M., O'Halloran, T. V. & Spring, B.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • biostatistics 15%
  • university research 12%
  • outreach 12%
  • prostatic neoplasms 12%

• The Robert H. Lurie Comprehensive Cancer Center: CPSRMS

  Benson III, A. B., Benson III, A. B. & Benson III, A. B.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • biostatistics 15%
  • university research 12%
  • outreach 12%
  • prostatic neoplasms 12%

• The Robert H. Lurie Comprehensive Cancer Center: Senior Leadership

  Gordon, L. I., Platanias, L. C., Woodruff, T. K., Platanias, L. C. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • leadership 90%
  • biostatistics 15%
  • university research 12%
  • outreach 12%

• The Robert H. Lurie Comprehensive Cancer Center - CURE Supplement

  Leikin, R. G., Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Leikin, R. G., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • biostatistics 15%
  • university research 12%
  • outreach 12%
  • prostatic neoplasms 12%

• The Robert H. Lurie Comprehensive Cancer Center - Administrative Core

  Benson III, A. B., Bulun, S. E., Catalona, W. J., Chatterton Jr, R. T., Chisholm, R. L., Chmiel, J. S., Goolsby, C. L., Gordon, L. I., Greenland, P., Jovanovic, B., Kibbe, M. R., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Platanias, L. C., Rademaker, A. W., Scholtens, D. M., Tourtellotte, W., Woodruff, T. K., Yang, X. J., Benson III, A. B., Chatterton Jr, R. T., Chisholm, R. L., Goolsby, C. L., Gordon, L. I., Greenland, P., Iannaccone, P. M., Jovanovic, B., Kozlowski, J. M., Kuzel, T. M., Lee, C., Longnecker, R. M., Mondragon, A., O'Halloran, T. V., Rademaker, A. W. & Woodruff, T. K.

  National Cancer Institute

  8/1/01 → 7/31/07

  Project: Research project

  • neoplasms 100%
  • biostatistics 15%
  • university research 12%
  • outreach 12%
  • prostatic neoplasms 12%

• Prot# NCI 00B9: Phase I/II Trial of in vivo Angiostatin Generation with Tissue Plasminogen Activator (t-PA) and Captopril in Patients with Progressive, Metastatic Breast Cancer

  Gradishar, W. J.

  Genentech, Inc.

  7/12/01 → 6/5/05

  Project: Research project

• Prot# 440E-ONC-0047-140: Phz I Dose-Escalation Study to Eval. Max Tolerated Dose, Safety Profile & Bioavailability of Semi-Solid Matrix (SSM) Capsule Formulation of Orally Admin'd Irinotecan Hydrochloride (CPT-11) Given Alone or in Sequence w/ Orally Admi

  Benson III, A. B.

  Pharmacia & Upjohn, Inc.

  6/12/01 → 9/6/07

  Project: Research project